One Stage Correction of Congenital Penile Curvature Complex (Al-AzharCPCC)

November 13, 2020 updated by: dr. Muhammad Abdelhafez Mahmoud, MD
To present update & experience in management of congenital penile curvature complex.

Study Overview

Detailed Description

Type of study: prospective study

Review of literature:

  • Different modalities of urethroplasty for correction of CPCC without hypospadias (Nesbit, modified Nesbit, dorsal dartos flap, combined plication-incision CPI, suture fixation to pubic bone).
  • Merits of modified Nesbit technique accompanied by dorsal dartos flap for one-stage correction of CPCC without hypospadias.

This is a prospective study conducted at pediatric surgery department, New Damietta & Alhoussain Al-Azhar University Hospitals, from January 2015 to May 2020, on 56 male patients with isolated CPCC. All of them will undergo one-stage correction corporoplasty using modified Nesbit technique accompanied by dorsal dartos flap.

Institutes of the study:

A multicenter study at Pediatric Surgery Departments, Al-Azhar University hospitals at New Damietta & Cairo. Number of cases: Fifty-six male patients. Time frame: period of 5.6 years.

Ethical Consideration:

The protocol will be discussed and approved for clinical study by the Ethical Research Committee at the principal investigator's hospital. The study protocol was approved by local research and ethics committee of Al-Azhar Faculty of Medicine; the study protocol was explained to all guardians and their informed consents were obtained for involvement in the study. Confidentiality and the right to withdraw from the study at any time were guaranteed.

Preoperative preparation:

Children with CPCC those fulfill inclusion criteria will undergo a nursing evaluation of functional health status and a preoperative evaluation by an anesthesiologist & pediatrician. The angle of penile rotation will be measured on the photograph, using Millen Med DICOM viewer program for image analysis, based on the orientation of the urethral meatus relative to the vertical position.

Follow-up:

Patients will be followed-up at OPD.

Statistical Analysis:

Data will be summarized into continuous variables expressed as mean ± standard deviation and categorical variables expressed as frequency count and percentage (%), using appropriate software computer package. Fisher's exact test is used for comparison of frequency counts/percentage. A two-sided p-value < 0.05 is considered statistically significant.

Discussion:

It will focus on one-stage correction of congenital penile curvature complex (CPCC) using modified Nesbit's procedure (to correct curvature) and dorsal dartos flap (to correct torsion). The results obtained from this study will be compared between both group and with those reported in the literature. Also, it will focus on results, complications, their management, and clinical evaluation by noticing urine stream direction. At the end, the investigators will conclude that this technique ensures correction of the complex penile anomaly with satisfactory results and nice cosmetic outcome.

Study Type

Interventional

Enrollment (Actual)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 34517
        • Mohamed M Shahin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 6 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • 2 to 10 years old boys
  • with congenital curvature complex of the penis
  • with normally situated urethral meatus.
  • The various degrees of penile curvature ranged between 30° - 90° associated with 30° - 90° penile rotation

Exclusion Criteria:

  • Boys with CPCC with abnormal urethral meatus as hypospadias or epispadias, or
  • with the range of angle degree of penile curvature less than 30° associated with less than 30° penile rotation or
  • with acquired penile curvature or
  • having an isolated lesion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Modified Nesbit technique followed by dorsal dartos flap
Modified Nesbit technique to correct penile curvature followed by dorsal dartos flap to correct penile torsion
Modified Nesbit's procedure to correct the penile curvature and dorsal dartos flap to correct the associated penile torsion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clockwise rotation
Time Frame: 5 years
Clockwise rotation of the penis (number & percent)
5 years
Counterlockwise rotation
Time Frame: 5 years
Counterlockwise rotation of the penis (number & percent)
5 years
Ventral Curvature
Time Frame: 5 years
Ventral Curvature of the penis (number & percent)
5 years
Dorsal Curvature
Time Frame: 5 years
Dorsal Curvature of the penis (number & percent)
5 years
Lateral Curvature
Time Frame: 5 years
Lateral Curvature of the penis (number & percent)
5 years
Age
Time Frame: 5 years
Age of the patients (years)
5 years
Operative time
Time Frame: 1 day (day of surgery)
Operative time (minutes)
1 day (day of surgery)
Post-operative hospital stay
Time Frame: 1 week
Hospital stay period (days)
1 week
Post-operative follow-up period
Time Frame: 5 years
Follow-up period (months)
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional impairment
Time Frame: 5 years
Functional impairment (number & percent)
5 years
Aesthetic impairment
Time Frame: 5 years
Aesthetic impairment (number & percent)
5 years
Residual curvature > 10°
Time Frame: 5 years
Residual curvature > 10° (number & percent)
5 years
Residual rotation > 10°
Time Frame: 5 years
Residual rotation > 10° (number & percent)
5 years
Post-operative paresthesia
Time Frame: 5 years
Post-operative paresthesia (number & percent)
5 years
Skin ischemia
Time Frame: 5 years
Skin ischemia (number & percent)
5 years
Hematoma
Time Frame: 5 years
Hematoma (number & percent)
5 years
Dressing soaked with blood
Time Frame: 5 years
Dressing soaked with blood (number & percent)
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mohamed M Shahin, MD,PhD, Al-Azhar New Damietta University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

November 1, 2019

Study Completion (Actual)

May 1, 2020

Study Registration Dates

First Submitted

November 13, 2020

First Submitted That Met QC Criteria

November 13, 2020

First Posted (Actual)

November 19, 2020

Study Record Updates

Last Update Posted (Actual)

November 19, 2020

Last Update Submitted That Met QC Criteria

November 13, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Al-AzharCPCC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Data will be available for other researchers including methodology, figures, tables, results, and philosophy of discussion and the value this study will add to the literature

IPD Sharing Time Frame

from now indefinitely

IPD Sharing Access Criteria

after the article became accepted and available online.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congenital Anomaly

Clinical Trials on Modified Nesbit's procedure and dorsal dartos flap

Subscribe